• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Kelly Filchner Highlights Obstacles, Benefits of Transitioning Patients From Cancer Care to PCPs

Video

Raising awareness on the involvement of primary care providers can assist cancer survivors in transitioning from oncology care, said Kelly Filchner, MSN, director at Fox Chase Cancer Center Partners.

Raising awareness on the involvement of primary care providers can assist cancer survivors in transitioning from oncology care, said Kelly Filchner, MSN, director at Fox Chase Cancer Center Partners.

Transcript

Are there challenges with getting patients to make the transition to their primary care provider (PCP)?

Educating patients from the beginning that their PCP is part of it, they get a little scared. You're going through cancer care, and you're followed so closely for perhaps a year at a time, maybe more than a year, depending on what your treatment is. Then all of a sudden, it's like, okay, you're a survivor, and now you're going to go do this, and it kind of scares people. So, we just need to make sure that they know that the PCP has been involved from the beginning. They know what's going on, and this is what we're going to do in oncology—we're going to take care of your side effects that you still might have, and we're going to make sure you're getting your CAT scans or whatever you need to follow your cancer, but your PCP is going to take care of making sure that even if you're a woman and you had a breast cancer, that you're still going for your colonoscopy, and other screening measures, as well as, taking care of exercise and obesity if that's an issue for that patient, along with their other comorbid conditions.

Related Videos
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Dr Debra Patt
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
ASCO GI 2026 Recap
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Dr Marco del Riccio
Bhavana (Tina) Bhatnagar, DO, West Virginia University Cancer Institute at Wheeling Hospital
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.